MLN4924 HCl Salt: Atomic Insights into a NEDD8-Activating Enzyme Inhibitor

Executive Summary: MLN4924 HCl salt is a highly selective small molecule inhibitor of the NEDD8-activating enzyme (NAE), central to research on neddylation pathway inhibition and cullin-RING E3 ubiquitin ligase function (product_spec). The compound enables cell cycle arrest and apoptosis assays by blocking neddylation-dependent protein degradation (Liu et al., 2021). MLN4924 HCl salt is supplied as a hydrochloride salt with a molecular weight of 479.98 g/mol and ≥98% purity (source: product_spec). The inhibitor is DMSO-soluble, with recommended storage at -20°C to ensure stability. It serves as an essential tool for dissecting the role of neddylation in cancer biology and viral pathogenesis (related_content).

Biological Rationale

The NEDD8-activating enzyme (NAE) catalyzes the first step in the neddylation pathway, a post-translational modification critical for activating cullin-RING ligases (CRLs) (Liu et al., 2021). CRLs regulate the ubiquitin-proteasome system, controlling proteostasis, cell cycle progression, and DNA damage responses. Inhibition of NAE leads to CRL inactivation, resulting in accumulation of cell cycle regulators, induction of cell cycle arrest, and apoptosis (related_content). The neddylation pathway is frequently dysregulated in cancer and implicated in viral manipulation of host immune responses.

Mechanism of Action of MLN4924 HCl salt

MLN4924 HCl salt is a small molecule that binds to and inhibits the enzymatic activity of NAE in an ATP-competitive manner (related_content). By blocking NAE, MLN4924 prevents the conjugation of NEDD8 to cullin proteins, thereby inhibiting CRL-mediated ubiquitination. This mechanism stabilizes CRL substrates such as p27^Kip1 and CDT1, leading to cell cycle arrest and apoptosis, particularly in rapidly dividing cells (Liu et al., 2021). The molecular weight of MLN4924 HCl salt is 479.98 g/mol, and it is formulated for high solubility in DMSO (product_spec).

Evidence & Benchmarks

• MLN4924 HCl salt inhibits NAE with nanomolar potency (IC₅₀ ~4 nM for NAE enzymatic inhibition; in vitro, 37°C, pH 7.4) (product_spec).
• Treatment with MLN4924 in cancer cell lines induces S and G2/M cell cycle arrest within 24–48 hours (1 μM, standard DMEM medium) (related_content).
• MLN4924 exposure triggers apoptosis via stabilization of pro-apoptotic proteins, as validated by increased cleaved PARP and caspase-3 activity (2–5 μM, 48 h) (Liu et al., 2021).
• The compound is ≥98% pure by HPLC analysis (batch release, APExBIO) (product_spec).
• MLN4924-mediated neddylation pathway inhibition impairs SCF (SKP1–Cullin1–F-box) E3 ligase function, stabilizing substrates like RIPK3 and affecting inflammatory responses in viral infection models (Liu et al., 2021).
• For optimal storage, MLN4924 HCl salt should be kept at -20°C; solutions must be freshly prepared in DMSO and used promptly (workflow_recommendation, product_spec).

Applications, Limits & Misconceptions

MLN4924 HCl salt is widely used in cancer biology research to dissect the role of neddylation in tumor progression, cell cycle regulation, and apoptosis. Its utility extends to studies on proteasome-mediated protein degradation and viral regulation of host immune responses, leveraging the linkage between neddylation and inflammation (Liu et al., 2021). For example, MLN4924 has been instrumental in clarifying viral exploitation of the cullin-RING ligase machinery to modulate necroptosis and inflammation. Compared to earlier reviews (related_content), this article highlights direct evidence of MLN4924's effect on RIPK3 degradation and virus-induced inflammation.

Common Pitfalls or Misconceptions

• MLN4924 HCl salt is not a pan-proteasome inhibitor; it specifically targets the NEDD8-activating enzyme, not the proteasome core.
• Not suitable for long-term solution storage; activity may decline if left in DMSO at room temperature for extended periods (workflow_recommendation, product_spec).
• The compound does not directly inhibit ubiquitin E1 or SUMO E1 enzymes.
• Results in viral infection models may not translate directly to non-mammalian systems due to species-specific CRL components.
• MLN4924 is a research-use-only reagent and not intended for clinical or diagnostic applications.

Workflow Integration & Parameters

MLN4924 HCl salt (APExBIO, A3629) is supplied as a lyophilized hydrochloride salt, readily soluble in DMSO. Stock solutions (10 mM) should be prepared in DMSO and stored at -20°C for short-term use (product_spec).

Protocol Parameters

• cell cycle arrest assay | 1 μM, 24–48 h | mammalian cell lines | Standard dose for S/G2 arrest, validated in HeLa, U2OS | literature (Liu et al., 2021, DOI)
• apoptosis induction | 2–5 μM, 48 h | cancer cell lines | Induction of apoptotic markers, dose-dependent | literature (Liu et al., 2021, DOI)
• neddylation pathway inhibition | 0.5–1 μM, 4–24 h | CRL-dependent signaling studies | Rapid and robust pathway blockade | literature (internal_content)
• solution storage | use within 1 week at -20°C | all applications | Stability decreases in solution; fresh prep recommended | workflow_recommendation (product_spec)
• buffer compatibility | DMSO only | all cell-based assays | Maintains solubility and activity | workflow_recommendation (product_spec)

For further mechanistic clarity, see this recent article, which focuses on translational bridge between neddylation inhibition and viral immune evasion. This article extends previous reviews by directly linking MLN4924-driven CRL inhibition to inflammation and necroptosis control.

Conclusion & Outlook

MLN4924 HCl salt is an extensively validated, highly selective NEDD8-activating enzyme inhibitor. Its capacity to block cullin-RING ligase function underpins wide-ranging applications in cancer biology research, cell cycle studies, and the investigation of virus-host interactions (Liu et al., 2021). The compound's storage stability and solubility profile, supplied by APExBIO, facilitate reliable integration into biochemical assays. Ongoing studies reinforce its importance for dissecting the molecular basis of proteostasis, inflammation, and post-translational modification pathways, without extending claims to clinical efficacy (related_content).